Gary M.  Owens net worth and biography

Gary Owens Biography and Net Worth

Gary Owens joined Mesa in March of 2017 as Mesa’s Chief Operating Officer (COO), and then was promoted to the role of President and Chief Executive Officer (CEO) in September of the same year. Mr. Owens had previously worked for the Danaher Corporation, joining the multi-billion dollar global science and technology innovator in 2006. At Danaher, he held various VP positions with responsibility for acquiring and integrating a number of new companies as well as leading portions of Beckman Coulter Life Sciences as General Manager. Prior to that, Gary worked in the technology field successfully overseeing the development of several software product lines while expanding sales channels and networks. Mr. Owens received his Bachelor of Science in Engineering degree from Tulane University and his MBA from the Columbia Business School.

What is Gary M. Owens' net worth?

The estimated net worth of Gary M. Owens is at least $6.06 million as of October 28th, 2024. Mr. Owens owns 45,888 shares of Mesa Laboratories stock worth more than $6,060,887 as of December 21st. This net worth evaluation does not reflect any other assets that Mr. Owens may own. Additionally, Mr. Owens receives a salary of $1,100,000.00 as CEO at Mesa Laboratories. Learn More about Gary M. Owens' net worth.

How old is Gary M. Owens?

Mr. Owens is currently 56 years old. There are 2 older executives and no younger executives at Mesa Laboratories. Learn More on Gary M. Owens' age.

What is Gary M. Owens' salary?

As the CEO of Mesa Laboratories, Inc., Mr. Owens earns $1,100,000.00 per year. Learn More on Gary M. Owens' salary.

How do I contact Gary M. Owens?

The corporate mailing address for Mr. Owens and other Mesa Laboratories executives is 12100 W 6TH AVE, LAKEWOOD CO, 80228. Mesa Laboratories can also be reached via phone at (303) 987-8000 and via email at [email protected]. Learn More on Gary M. Owens' contact information.

Has Gary M. Owens been buying or selling shares of Mesa Laboratories?

During the last quarter, Gary M. Owens has sold $286,095.16 in Mesa Laboratories stock. Most recently, Gary M. Owens sold 2,518 shares of the business's stock in a transaction on Monday, October 28th. The shares were sold at an average price of $113.62, for a transaction totalling $286,095.16. Following the completion of the sale, the chief executive officer now directly owns 45,888 shares of the company's stock, valued at $5,213,794.56. Learn More on Gary M. Owens' trading history.

Who are Mesa Laboratories' active insiders?

Mesa Laboratories' insider roster includes Brian Archbold (SVP), Gregory DiNoia (SVP), Evan Guillemin (Director), David Kelly (Director), Gary Owens (CEO), John Sakys (CFO), John Schmieder (Director), and John Sullivan (Director). Learn More on Mesa Laboratories' active insiders.

Are insiders buying or selling shares of Mesa Laboratories?

During the last twelve months, insiders at the medical instruments supplier sold shares 2 times. They sold a total of 4,017 shares worth more than $473,470.16. The most recent insider tranaction occured on October, 28th when CEO Gary M Owens sold 2,518 shares worth more than $286,095.16. Insiders at Mesa Laboratories own 4.4% of the company. Learn More about insider trades at Mesa Laboratories.

Information on this page was last updated on 10/28/2024.

Gary M. Owens Insider Trading History at Mesa Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/28/2024Sell2,518$113.62$286,095.1645,888View SEC Filing Icon  
9/1/2023Sell2,000$142.82$285,640.0030,032View SEC Filing Icon  
6/21/2022Sell1,756$188.22$330,514.3221,640View SEC Filing Icon  
6/16/2021Sell6,545$255.67$1,673,360.1524,941View SEC Filing Icon  
6/7/2021Sell1,350$264.00$356,400.008,513View SEC Filing Icon  
10/8/2020Sell1,000$275.62$275,620.0010,186View SEC Filing Icon  
10/6/2020Sell1,000$265.00$265,000.0010,863View SEC Filing Icon  
See Full Table

Gary M. Owens Buying and Selling Activity at Mesa Laboratories

This chart shows Gary M Owens's buying and selling at Mesa Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mesa Laboratories Company Overview

Mesa Laboratories logo
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. The Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. The Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems, offered under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
Read More

Today's Range

Now: $132.08
Low: $129.75
High: $136.27

50 Day Range

MA: $120.47
Low: $98.59
High: $135.91

2 Week Range

Now: $132.08
Low: $83.68
High: $141.17

Volume

141,746 shs

Average Volume

41,646 shs

Market Capitalization

$717.19 million

P/E Ratio

N/A

Dividend Yield

0.50%

Beta

0.86